ResMed News

ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Rider Michael J

Mar 6 20:50 ET

ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Rider Michael J

Mar 4 19:16 ET

ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 4 17:58 ET

ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 1 17:12 ET

ResMed | 4: Statement of changes in beneficial ownership of securities-Director FARRELL PETER C

Feb 23 18:45 ET

ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 22 21:43 ET

ResMed | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(12.56%)

Feb 13 22:37 ET

ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 6 11:27 ET

ResMed | 10-Q: Quarterly report

Jan 25 15:36 ET

ResMed | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.7%)

Jan 25 13:50 ET

ResMed | 8-K: ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024

Jan 24 16:12 ET

ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Douglas Robert Andrew

Jan 3 00:00 ET

ResMed | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Sandercock Brett

Nov 29, 2023 19:45 ET

ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 27, 2023 17:26 ET

ResMed | 4: Statement of changes in beneficial ownership of securities-Officer Rider Michael J

Nov 27, 2023 16:33 ET

ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 22, 2023 17:01 ET

ResMed | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 22, 2023 12:58 ET

ResMed | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Burt Carol

Nov 21, 2023 16:36 ET

ResMed | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Farrell Michael J.

Nov 20, 2023 21:14 ET

ResMed | 4: Statement of changes in beneficial ownership of securities-Director SULPIZIO RICHARD

Nov 20, 2023 20:28 ET